Benitec Biopharma Limited P/S ratio

P/S ratio of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/S ratio growth rates and interactive chart. A valuation metric that measures the share price of a stock compared to its sales per share. It is used by investors mainly because it’s less volatile than P/E and less subject to accounting manipulation. A low P/S ratio compare to historical average or other companies in the same industry might indicate undervaluation.


Highlights and Quick Summary

Current P/S ratio of Benitec Biopharma Limited is 0.63 (as of June 30, 2022)
  • P/S ratio for the quarter ending June 30, 2022 was 0.63 (a -99.92% decrease compared to previous quarter)
  • Year-over-year quarterly P/S ratio decreased by -99.97%
  • Annual P/S ratio for 2022 was 0.63 (a -99.97% decrease from previous year)
  • Annual P/S ratio for 2021 was 1859.16 (a 124175.33% increase from previous year)
  • Annual P/S ratio for 2021 was 1.5 (a 278.26% increase from previous year)
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/S ratio of Benitec Biopharma Limited

Most recent P/S ratioof BNTC including historical data for past 10 years.

Interactive Chart of P/S ratio of Benitec Biopharma Limited

Benitec Biopharma Limited P/S ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.63 794.66 0.63
2021 2331.75 1859.16 3691.19 1859.16
2020 1.34 0.3 0.4 0.04 0.4
2019 0.01 0.0 0.0
2018 0.0
2017 0.0 0.0
2016 0.0 0.0
2015 0.0
2014 0.0
2013 0.0

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology